Skip to content
Advisory Council on the Misuse of Drugs (UK)·PickAI score62

UK advisory council publishes updated review of ketamine use and harms

Research: Ketamine: an updated review of use and harms

AI summary

The Advisory Council on the Misuse of Drugs has published an updated review of the use and harms of ketamine, following a commission from the then Minister for Policing, Fire and Crime Prevention in January 2025. The report reviews prevalence and harms of ketamine and its analogues in the UK, describes legitimate uses including treatment and research, covers emerging health harms such as hepatobiliary toxicity, and describes supply and trafficking.

Why it matters

The review was commissioned to advise on ketamine's classification, so its findings on prevalence, hepatobiliary toxicity and supply could shape how the UK schedules the drug and its analogues.

Key facts

Jurisdiction
United Kingdom
Source
Advisory Council on the Misuse of Drugs (UK) (gov.uk)
Published
How this summary was made

The summary and the “Why it matters” note were written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method

Source: Advisory Council on the Misuse of Drugs (UK) · gov.uk

Connected to

Jurisdiction
United Kingdom